Levonorgestrel Exeltis

Levonorgestrel, the active ingredient in Levonorgestrel Exeltis, is a progestin presented as an oral tablet for oral use. It prevents pregnancy and is used for emergency contraception and regular hormonal birth control.

GNH USA supplies Levonorgestrel Exeltis as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levonorgestrel Exeltis is a progestin‑based hormonal agent used in contraception and related pathways. - Emergency contraception: provides a high‑dose regimen to prevent pregnancy after unprotected intercourse. - Regular contraception: incorporated into daily oral regimens to inhibit ovulation and maintain contraceptive efficacy. - Menstrual cycle regulation: may be used under medical supervision to adjust cycle timing and reduce heavy bleeding.

Levonorgestrel Exeltis may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nausea or vomiting - Headache - Breast tenderness - Irregular bleeding or spotting - Mood changes - Abdominal cramping

Serious or Rare Side Effects: - Deep vein thrombosis or pulmonary embolism - Severe allergic reaction (anaphylaxis) - Liver dysfunction - Persistent high blood pressure - Vision changes

Before using Levonorgestrel Exeltis, consider the following safety measures. - Contraindications: Do not use if you have a known hypersensitivity to levonorgestrel or any excipients. - Pregnancy: Avoid use if you are already pregnant; the product is intended for prevention, not termination. - Breastfeeding: Consult a healthcare professional before use while nursing. - Drug interactions: Review concomitant medications that may reduce efficacy. - Medical conditions: Use caution in patients with liver disease, uncontrolled hypertension, or clotting disorders. - Store at ambient temperature: Keep below 25 °C, in the original packaging, protected from moisture and direct sunlight.

Levonorgestrel Exeltis can interact with other medicines, affecting its contraceptive effectiveness.

Major Interactions (Avoid): - Enzyme inducers (e.g., rifampicin, carbamazepine, phenytoin): may markedly reduce plasma levels. - Certain antiretrovirals (e.g., efavirenz): can decrease efficacy.

Moderate Interactions (Monitor Closely): - Antifungal agents (e.g., ketoconazole): may increase levonorgestrel concentrations. - St. John’s wort: may lower effectiveness. - Anticonvulsants with moderate enzyme induction (e.g., phenobarbital): require monitoring. - Herbal supplements affecting hormone metabolism: advise patient to discuss use.